NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company focused on improving surgical care for neurological disorders, announced today that it will participate in the Planet MicroCap Las Vegas 2026 Conference, scheduled for June 17-18, 2026. President and CEO Dave Rosa will attend the conference in Las Vegas, Nevada, where he will host one-on-one meetings with institutional investors and deliver a company presentation on Wednesday, June 17, 2026, at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern Time in TRACK 6 - Raphael 3.
During the presentation, Rosa is expected to provide commercialization updates and discuss anticipated milestones for the OneRF platform, which is designed for treatment of the brain, pain management, and advanced drug delivery. The OneRF platform includes the OneRF Ablation System for brain procedures and the OneRF Trigeminal Nerve Ablation System, both of which have received FDA clearance. These technologies offer minimally invasive solutions that may reduce hospitalizations, lower costs, and improve patient outcomes.
In addition to the live presentation, Rosa participated in a CEO interview with Planet MicroCap host Robert Kraft ahead of the conference, which can be viewed here. The webcast of the presentation will also be available here. For more information about the conference or to schedule a meeting with management, interested parties can contact Chris Tyson at (949) 491-8235 or email NMTC@mzgroup.us.
NeuroOne markets a portfolio of FDA-cleared products, including Evo Cortical Electrodes, Evo sEEG Electrodes, and the OneRF Ablation Systems. The company is also engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs. This conference appearance underscores NeuroOne's commitment to advancing neurological treatments and engaging with the investment community.
